华邦健康
(002004)
| 流通市值：79.05亿 | | | 总市值：83.16亿 |
| 流通股本：18.82亿 | | | 总股本：19.80亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 2,820,969,309.75 | 11,664,669,783.79 | 8,909,836,679.88 | 5,922,042,354.85 |
| 营业收入 | 2,820,969,309.75 | 11,664,669,783.79 | 8,909,836,679.88 | 5,922,042,354.85 |
| 二、营业总成本 | 2,540,921,781.44 | 10,758,061,028.78 | 8,114,670,346.58 | 5,370,629,390.07 |
| 营业成本 | 1,773,938,403.36 | 7,683,859,359.93 | 5,629,798,504.13 | 3,747,661,339.12 |
| 税金及附加 | 31,911,391.88 | 129,149,704.88 | 98,976,738.22 | 65,451,526.03 |
| 销售费用 | 300,584,294.93 | 1,021,953,508.93 | 896,944,174.99 | 635,971,224.06 |
| 管理费用 | 272,086,044.31 | 1,277,742,199.4 | 953,561,648.45 | 591,833,633.24 |
| 研发费用 | 107,103,304.5 | 375,319,013.67 | 301,716,088.01 | 190,304,390.17 |
| 财务费用 | 55,298,342.46 | 270,037,241.97 | 233,673,192.78 | 139,407,277.45 |
| 其中:利息费用 | 73,001,380.1 | 349,974,105.54 | 263,838,241.88 | 177,477,703.22 |
| 其中:利息收入 | 13,272,465.01 | 69,659,912.52 | 48,493,362.3 | 35,168,704.15 |
| 加:公允价值变动收益 | 622,260.29 | 3,097,277.73 | 922,533.86 | -169,375.24 |
| 加:投资收益 | 12,700,521.39 | -172,079,130.75 | -50,134,221.39 | -11,733,497.63 |
| 资产处置收益 | 2,978,628.75 | 3,752,750.93 | 3,888,656.97 | 3,814,784.27 |
| 资产减值损失(新) | 104,819.07 | -929,742,732.37 | -16,310,776.11 | -11,745,270.41 |
| 信用减值损失(新) | -5,682,820.22 | -33,629,022.75 | -6,869,990.29 | -4,786,957.99 |
| 其他收益 | 19,541,583.62 | 94,557,094.96 | 57,424,963.96 | 35,551,029.03 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 310,312,521.21 | -127,435,007.24 | 784,087,500.3 | 562,343,676.81 |
| 加:营业外收入 | 1,122,512.21 | 12,929,819.42 | 6,690,304.94 | 4,902,193.38 |
| 减:营业外支出 | 1,791,342.25 | 46,001,995.43 | 22,332,641.06 | 13,024,749.57 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 309,643,691.17 | -160,507,183.25 | 768,445,164.18 | 554,221,120.62 |
| 减:所得税费用 | 68,845,204.05 | 182,086,373.63 | 183,328,358.37 | 130,012,257.75 |
| 六、净利润 | 240,798,487.12 | -342,593,556.88 | 585,116,805.81 | 424,208,862.87 |
| 持续经营净利润 | 240,798,487.12 | -342,593,556.88 | 585,116,805.81 | 424,208,862.87 |
| 归属于母公司股东的净利润 | 184,340,340.89 | -298,989,917.1 | 451,977,453.17 | 313,522,665.65 |
| 少数股东损益 | 56,458,146.23 | -43,603,639.78 | 133,139,352.64 | 110,686,197.22 |
| (一)基本每股收益 | 0.09 | -0.15 | 0.23 | 0.16 |
| (二)稀释每股收益 | 0.09 | -0.15 | 0.23 | 0.16 |
| 八、其他综合收益 | 11,754,995.9 | -36,412,599.46 | -69,850,813.11 | -32,383,081.04 |
| 归属于母公司股东的其他综合收益 | 5,646,710.4 | -17,889,642.46 | -33,462,126.23 | -15,688,757.44 |
| 九、综合收益总额 | 252,553,483.02 | -379,006,156.34 | 515,265,992.7 | 391,825,781.83 |
| 归属于母公司股东的综合收益总额 | 189,987,051.29 | -316,879,559.56 | 418,515,326.94 | 297,833,908.21 |
| 归属于少数股东的综合收益总额 | 62,566,431.73 | -62,126,596.78 | 96,750,665.76 | 93,991,873.62 |
| 公告日期 | 2025-04-23 | 2025-04-23 | 2024-10-29 | 2024-08-31 |
| 审计意见(境内) | | 标准无保留意见 | | |